menu
    • menu

    Company profile for Kallyope

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Kallyope, we are developing an industry-leading therapeutic platform based on our comprehensive understanding of gut-brain biology. Founded and headquartered in New York City, our cross-disciplinary team is integrating cutting-edge technologies in sequencing, computational biology, neural imaging, cellular and molecular biology and human genetics to provide an understanding of gut-brain biology that, when coupled with our d...
    At Kallyope, we are developing an industry-leading therapeutic platform based on our comprehensive understanding of gut-brain biology. Founded and headquartered in New York City, our cross-disciplinary team is integrating cutting-edge technologies in sequencing, computational biology, neural imaging, cellular and molecular biology and human genetics to provide an understanding of gut-brain biology that, when coupled with our deep drug discovery expertise, will lead to transformational therapeutics to improve human health.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    KallyopeUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    430 East 29th Street, 10th Floor | New York, NY 10016
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://kallyope.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/kallyope/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Crossroads Transforms Opioid Use Disorder Treatment
    Crossroads Transforms Opioid Use Disorder Treatment

    10 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240910844342/en

    BUSINESSWIRE
    10 Sep 2024
    Share Share
    Kallyope Enters Phase 2 With First-in-class Oral Approach
    Kallyope Enters Phase 2 With First-in-class Oral Approach

    27 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230927390827/en

    BUSINESSWIRE
    27 Sep 2023
    Share Share
    Kallyope Appoints Franz Humer, Ph.D., as Chair of its Board of Directors
    Kallyope Appoints Franz Humer, Ph.D., as Chair of its Board of Directors

    06 Jun 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230606005244/en

    BUSINESSWIRE
    06 Jun 2023
    Share Share
    Kallyope, Pioneers in Drug Discovery via Gut-Brain Axis, With New Appointments
    Kallyope, Pioneers in Drug Discovery via Gut-Brain Axis, With New Appointments

    06 Jul 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220706005265/en

    BUSINESSWIRE
    06 Jul 2022
    Share Share
    Sosei Heptares and Kallyope Enter Collaboration for Novel GI GPCR Targets
    Sosei Heptares and Kallyope Enter Collaboration for Novel GI GPCR Targets

    17 May 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/05/17/2444528/0/en/Sosei-Heptares-and-Kallyope-Enter-Collaboration-to-Identify-and-Validate-Novel-Gastrointestinal-GPCR-Targets-for-Drug-Discovery.html

    GLOBENEWSWIRE
    17 May 2022
    Share Share
    Kallyope delays IPO to snag $236M series D for 22 programs
    Kallyope delays IPO to snag $236M series D for 22 programs

    16 Feb 2022

    // M. Fitzhugh BIOWORLD

    https://www.bioworld.com/articles/516083-kallyope-raises-236m-for-drugs-targeting-gut-brain-axis?v=preview

    M. Fitzhugh BIOWORLD
    16 Feb 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search